Luukkaa H, Laitakari J, Vahlberg T, Klemi P, Stenbäck F, Grénman R
Department of Otorhinolaryngology - Head and Neck Surgery, University of Turku, Turku, Finland.
J Oral Pathol Med. 2009 Oct;38(9):695-700. doi: 10.1111/j.1600-0714.2009.00810.x. Epub 2009 Aug 6.
Carcinomas of the salivary glands are uncommon and morphologically a diverse group of malignancies. To evaluate the prognostic value of CD34 immunostaining of the vessels in adenoid cystic carcinoma (AdCC) and mucoepidermoid carcinoma (MEC), an automated image analysis method was used.
In a nationwide study, covering salivary gland cancer (SGC) patients in Finland 1991-1996, 37 AdCC and 18 MEC patients (M 25, F 30, age 25-90, mean 63) were included. In addition to clinical characteristics the size, shape, staining intensity and vessel density in CD34 immunostained histologic samples were measured.
Altogether 4433 vessels were measured from AdCC and 2615 from MEC tumor. Of the total tumor vessels measured, 2651 were from patients who deceased with disease (Group I) and 4397 were from specimens derived from those who did not die of disease (Group II) during the 10-year follow-up. The staining intensity was significantly higher in MEC than in AdCC tumor (P = 0.0005). In MEC, the Group I patients had a higher staining intensity among high-grade patients compared with patients with low grade disease, whereas the tumors in Group II had a lower staining intensity among the high-grade compared with the low grade tumors (P = 0.018). A higher vessel density was found in patients with MEC in group II compared with group I (P = 0.017).
The staining intensity of CD34 positive vessels in MEC was higher than in AdCC. In MEC, higher staining intensity of vessels in high-grade tumors and lower vessel density in all MEC patients, predicted poor survival.
唾液腺癌并不常见,在形态学上是一组多样的恶性肿瘤。为了评估血管CD34免疫染色在腺样囊性癌(AdCC)和黏液表皮样癌(MEC)中的预后价值,采用了一种自动图像分析方法。
在一项全国性研究中,纳入了1991 - 1996年芬兰唾液腺癌(SGC)患者,其中有37例AdCC患者和18例MEC患者(男性25例,女性30例,年龄25 - 90岁,平均63岁)。除了临床特征外,还测量了CD34免疫染色组织学样本中的血管大小、形状、染色强度和血管密度。
共测量了AdCC肿瘤中的4433条血管和MEC肿瘤中的2615条血管。在10年随访期间,所测量的肿瘤血管中,2651条来自因病死亡的患者(第一组),4397条来自未死于该病的患者的标本(第二组)。MEC肿瘤的染色强度显著高于AdCC肿瘤(P = 0.0005)。在MEC中,第一组患者中高级别患者的染色强度高于低级别疾病患者,而第二组肿瘤中高级别肿瘤的染色强度低于低级别肿瘤(P = 0.018)。第二组MEC患者的血管密度高于第一组(P = 0.017)。
MEC中CD34阳性血管的染色强度高于AdCC。在MEC中,高级别肿瘤血管的较高染色强度和所有MEC患者较低的血管密度预示着较差的生存率。